Dimethyl sulfoxide attenuates hydrogen peroxide-induced injury in cardiomyocytes via heme oxygenase-1

Journal of Cellular Biochemistry

Volumn 115, Issue 6, 2014, Pages 1159-1165

  Man, Wang ^a   Ming, Ding ^b   Fang, Du ^b   Chao, Liang ^b   Jing, Cang ^b  

^a The Central Hospital of Minhang District   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

CARDIOMYOCYTES; DIMETHYL SULFOXIDE; HEME OXYGENASE 1; HYDROGEN PEROXIDE

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASPASE 3; DIMETHYL SULFOXIDE; DODECYL SULFATE SODIUM; HEME OXYGENASE 1; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR NRF2; CRYOPROTECTIVE AGENT; NFE2L2 PROTEIN, RAT; OXIDIZING AGENT;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL PROTECTION; CELL VIABILITY; CELL VIABILITY ASSAY; CONTROLLED STUDY; CYTOLYSIS; CYTOPLASM; DNA BINDING; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; HEART MUSCLE CELL; HEART PROTECTION; IN VITRO STUDY; MTT ASSAY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ACTIVE TRANSPORT; ANIMAL; CELL LINE; CELL NUCLEUS; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; METABOLISM; UPREGULATION; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CELL LINE; CELL NUCLEUS; CELL SURVIVAL; CRYOPROTECTIVE AGENTS; DIMETHYL SULFOXIDE; HEME OXYGENASE-1; HYDROGEN PEROXIDE; MYOCYTES, CARDIAC; NF-E2-RELATED FACTOR 2; OXIDANTS; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; UP-REGULATION;

EID: 84907422168     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24761     Document Type: Article

References (37)

1. Bassi R, Heads R, Marber MS, Clark JE,. 2008. Targeting p38-MAPK in the ischaemic heart: Kill or cure? Curr Opin Pharmacol 8: 141-146.
2. Bulger EM, Maier RV,. 2001. Antioxidants in critical illness. Arch Surg 136: 1201-1207.
3. Camici GG, Steffel J, Akhmedov A, Schafer N, Baldinger, J, Schulz U, Shojaati, K, Matter CM, Yang Z, Lüscher TF, Tanner FC,. 2006. Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: A potential treatment strategy for drug-eluting stents. Circulation 114: 1512-1521.
4. Chen JC, Huang KC, Lin WW,. 2006. HMG-CoA reductase inhibitors upregulate heme oxygenase-1 expression in murine RAW264. 7 macrophages via ERK, p38 MAPK and protein kinase G pathways. Cell Signal 18: 32-39.
5. Chen C, Huo R, Tong Y, Sheng Y, Liu HB, Gao X, Nakajima O, Yang BF, Dong DL,. 2011. Systemic heme oxygenase-1 transgenic overexpression aggravates pressure overload-induced cardiac hypertrophy in mice. Cell Physiol Biochem 28: 25-32.
6. Chen XQ, Wu SH, Zhou Y, Tang YR,. 2013. Lipoxin A4-induced heme oxygenase-1 protects cardiomyocytes against hypoxia/reoxygenation injury via p38 MAPK activation and Nrf2/ARE complex. PLoS ONE 8: e67120.
7. Cooper KL, Liu KJ, Hudson LG,. 2007. Contributions of reactive oxygen species and mitogen-activated protein kinase signaling in arsenite-stimulated hemeoxygenase-1 production. Toxicol Appl Pharmacol 218: 119-127.
8. Dmitriev YV, Minasian SM, Demchenko EA, Galagudza MM,. 2012. Cardioprotective properties of dimethyl sulfoxide during global ischemia-reperfusion of isolated rat heart. Bull Exp Biol Med 154: 47-50.
9. Droge W,. 2002. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95.
10. Eltzschig HK, Eckle T,. 2011. Ischemia and reperfusion-From mechanism to translation. Nat Med 17: 1391-1401.
11. Y. Ergun, A. Koc, K. Dolapcioglu, Y. Akaydin, G. Dogruer, T. Kontas, T. Kozlu, E. Aslan, The protective effect of erythropoietin and dimethylsulfoxide on ischemia-reperfusion injury in rat ovary Eur J Obstet Gynecol Reprod Biol 152 2010; 186-190
12. Giovanni WM, Shearer DR, Nelson LR,. 1994. Human corneal endothelial tolerance to glycerol, dimethylsulfoxide, 1,2-propanediol, and 2,3-butanediol. Cryobiology 31: 1-9.
13. Guimaraes SB, Kimura OS, Vasconcelos PR,. 2010. Dimethylsulfoxide attenuates ischemia-reperfusion injury in rat testis. Acta Cir Bras 25: 357-361.
14. Heidari Y, Shah AM, Gove C,. 2004. NOX-2S is a new member of the NOX family of NADPH oxidases. Gene 335: 133-140.
15. Hescheler J, Meyer R, Plant S, Krautwurst D, Rosenthal W, Schultz G,. 1991. Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ Res 69: 1476-1486.
16. Hull TD, Bolisetty S, DeAlmeida AC, Litovsky SH, Prabhu SD, Agarwal A, George JF,. 2013. Heme oxygenase-1 expression protects the heart from acute injury caused by inducible Cre recombinase. Lab Invest 93: 868-879.
17. Hwa JS, Jin YC, Lee YS, Ko YS, Kim YM, Shi LY, Kim HJ, Lee JH, Ngoc TM, Bae KH, Kim YS, Chang KC,. 2012. 2-Methoxycinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1 induction. J Ethnopharmacol 139: 605-615.
18. Jacob SW, de la Torre JC,. 2009. Pharmacology of dimethyl sulfoxide in cardiac and CNS damage. Pharmacol Rep 61: 225-235.
19. Kacimi R, Chentoufi J, Honbo N, Long CS, Karliner JS,. 2000. Hypoxia differentially regulates stress proteins in cultured cardiomyocytes: role of the p38 stress-activated kinase signaling cascade, and relation to cytoprotection. Cardiovasc Res 46: 139-150.
20. Kashino G, Liu Y, Suzuki M, Masunaga S, Kinashi Y, Ono K, Tano K, Watanabe M,. 2010. An alternative mechanism for radioprotection by dimethyl sulfoxide; possible facilitation of DNA double-strand break repair. J Radiat Res 51: 733-740.
21. Koksal C, Bozkurt AK, Ustundag N, Konukoglu D, Musellim B, Sirin G, Cortelekoglu T, Sayin AG,. 2006. Attenuation of acute lung injury following lower limb ischemia/reperfusion: The pharmacological approach. J Cardiovasc Surg (Torino) 47: 445-449.
22. Lee YS, Kang YJ, Kim HJ, Park MK, Seo HG, Lee JH, Yun-Choi HS, Chang KC,. 2006. Higenamine reduces apoptotic cell death by induction of heme oxygenase-1 in rat myocardial ischemia-reperfusion injury. Apoptosis 11: 1091-1100.
23. Li MH, Jang JH, Na HK, Cha YN, Surh YJ,. 2007. Carbon monoxide produced by heme oxygenase-1 in response to nitrosative stress induces expression of glutamate-cysteine ligase in PC12 cells via activation of phosphatidylinositol 3-kinase and Nrf2 signaling. J Biol Chem 282: 28577-28586.
24. Liang C, Xue Z, Cang J, Wang H, Li P,. 2012. Dimethyl sulfoxide induces heme oxygenase-1 expression via JNKs and Nrf2 pathways in human umbilical vein endothelial cells. Mol Cell Biochem 355: 109-115.
25. Liang C, Xue Z, Wang H, Li P,. 2012. Propofol upregulates heme oxygenase-1 through activation of ERKs in human umbilical vein endothelial cells under oxidative stress conditions. J Neurosurg Anesthesiol 23: 229-235.
26. Liu XM, Peyton KJ, Ensenat D, Wang H, Hannink M, Alam J, Durante W,. 2007. Nitric oxide stimulates heme oxygenase-1 gene transcription via the Nrf2/ARE complex to promote vascular smooth muscle cell survival. Cardiovasc Res 75: 381-389.
27. Mann GE, Niehueser-Saran J, Watson A, Gao L, Ishii T, de Winter P, Siow RC,. 2007. Nrf2/ARE regulated antioxidant gene expression in endothelial and smooth muscle cells in oxidative stress: Implications for atherosclerosis and preeclampsia. Sheng Li Xue Bao 59: 117-127.
28. Masuya Y, Hioki K, Tokunaga R, Taketani S,. 1998. Involvement of the tyrosine phosphorylation pathway in induction of human heme oxygenase-1 by hemin, sodium arsenite, and cadmium chloride. J Biochem 124: 628-633.
29. Nagel S, Genius J, Heiland S, Horstmann S, Gardner H, Wagner S,. 2007. Diphenyleneiodonium and dimethylsulfoxide for treatment of reperfusion injury in cerebral ischemia of the rat. Brain Res 1132: 210-217.
30. Reilly PM, Schiller HJ, Bulkley GB,. 1991. Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am J Surg 161: 488-503.
31. Ryter SW, Choi AM,. 2007. Cytoprotective and anti-inflammatory actions of carbon monoxide in organ injury and sepsis models. Novartis Found Symp 280: 165-175; discussion 175-181.
32. Ryter SW, Kvam E, Tyrrell RM,. 2000. Heme oxygenase activity. Current methods and applications. Methods Mol Biol 99: 369-391.
33. Santos NC, Figueira-Coelho J, Martins-Silva J, Saldanha C,. 2003. Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochem Pharmacol 65: 1035-1041.
34. Schulz R, Belosjorow S, Gres P, Jansen J, Michel MC, Heusch G,. 2002. p38 MAP kinase is a mediator of ischemic preconditioning in pigs. Cardiovasc Res 55: 690-700.
35. Vulapalli SR, Chen Z, Chua BH, Wang T, Liang CS,. 2002. Cardioselective overexpression of HO-1 prevents I/R-induced cardiac dysfunction and apoptosis. Am J Physiol Heart Circ Physiol 283: H688-H694.
36. Wu CC, Hsieh CW, Lai PH, Lin JB, Liu YC, Wung BS,. 2006. Upregulation of endothelial heme oxygenase-1 expression through the activation of the JNK pathway by sublethal concentrations of acrolein. Toxicol Appl Pharmacol 214: 244-252.
37. Yellon DM, Hausenloy DJ,. 2007. Myocardial reperfusion injury. N Engl J Med 357: 1121-1135.